萬豐奧威(002085.SZ):航空工業完成轉讓飛機工業35%股權
格隆匯2月2日丨萬豐奧威(002085.SZ)公佈,萬豐航空工業有限公司(以下簡稱“航空工業”)將其所持有的萬豐飛機工業有限公司(以下簡稱“飛機工業”)35%股權以18.431億元價格轉讓給國資控制的青島萬盛城豐股權投資合夥企業(有限合夥)(以下簡稱“青島萬盛”),公司放棄上述股權轉讓的優先受讓權。
2021年2月1日接到航空工業的通知,航空工業與青島萬盛已完成飛機工業35%股權的交割,並辦理了工商變更登記手續。工商變更完成後,青島萬盛持有飛機工業35%股權;公司持有飛機工業55%股權,仍為飛機工業的控股股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.